Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young U.S. children with cystic fibrosis.

  • Read more about Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young U.S. children with cystic fibrosis.

Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis.

  • Read more about Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis.

Epidemiology of the Respiratory Bacteriology of Patients with Cystic Fibrosis

  • Read more about Epidemiology of the Respiratory Bacteriology of Patients with Cystic Fibrosis

Clinical Characteristics of Cystic Fibrosis Patients Prior to Lung Transplantation: An International Comparison Between Canada and the United States

  • Read more about Clinical Characteristics of Cystic Fibrosis Patients Prior to Lung Transplantation: An International Comparison Between Canada and the United States

Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012

  • Read more about Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012

Nasal Potential Difference in suspected Cystic Fibrosis patients with 5T: A step towards better characterization of a CFTR variant with varying clinical consequences

  • Read more about Nasal Potential Difference in suspected Cystic Fibrosis patients with 5T: A step towards better characterization of a CFTR variant with varying clinical consequences

Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis

  • Read more about Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis

Clinical trial participants compared with nonparticipants in cystic fibrosis

  • Read more about Clinical trial participants compared with nonparticipants in cystic fibrosis

Use is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis

  • Read more about Use is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis

Chronic Azithromycin Use in Cystic Fibrosis and Concern for Treatment-Emergent Pathogens

  • Read more about Chronic Azithromycin Use in Cystic Fibrosis and Concern for Treatment-Emergent Pathogens
  • first
  • previous
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)